YARW

YARROW BIOSCIENCE, INC.

• TipRanks·09/14 20:37

  Yarrow Bioscience Announces Underwritten Equity Offering Agreement

• Seeking Alpha·09/11 07:10

  Yarrow Bioscience prices $150M public offering of common stock at $26 per share

• Dow Jones·09/11 01:32

  *Yarrow Bioscience Offering Is Expected to Close on September 14 >YARW

• Dow Jones·09/11 01:32

  *Jefferies, TD Cowen, Guggenheim Securities Among Mangers for Offering >YARW

• Dow Jones·09/11 01:32

  *Yarrow Bioscience Intends to Use Proceeds to Fund R&D Expenses for Pipeline >YARW

• Dow Jones·09/11 01:31

  *Yarrow Bioscience Has Granted Underwriters Option for Additional 865,384 Shares >YARW

• Dow Jones·09/11 01:31

  *Yarrow Bioscience Offering of 5,769,231 Shares Priced at $26.00 Each >YARW

• TipRanks·09/11 01:20

  Yarrow Bioscience 5.77M share Spot Secondary priced at $26.00

• TipRanks·09/10 20:38

  Yarrow Bioscience Updates Strategy for Thyroid Autoimmune Pipeline

• TipRanks·09/10 20:05

  Yarrow Bioscience announces common stock offering, no amount given

• Benzinga·09/10 20:03

  Yarrow Bioscience Launches Underwritten Public Offering To Fund Pipeline Development And Corporate Operations; No Terms Disclosed

• TipRanks·09/04 16:30

  Yarrow Bioscience’s YB-101 Trial Targets Graves’ Disease, Raising New Investor Interest

• TipRanks·08/17 08:10

  Yarrow Bioscience reported Q2 EPS ($2.14)

• TipRanks·08/13 18:25

  Analyst Maintains Buy on Yarrow Bioscience, Sees Attractive Risk-Reward with Unchanged $56 Price Target

• Benzinga·08/13 11:17

  Yarrow Bioscience Q2 EPS $(2.14) Misses $(0.22) Estimate